You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

(1-6)-alpha-glucomannan

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetic Neuropathies, Diabetes, Dietary Supplement Trial in Thessaloníki (Epineuron, Placebo group)

Completed
  • Diabetic Neuropathies
  • +2 more
  • Epineuron
  • Placebo group
  • Thessaloníki, Thessaloniki, Greece
    University General Hospital AHEPA
Aug 8, 2023

Type 1 Diabetes Trial in Edmonton (Alpha-1 Antitrypsin)

Completed
  • Type 1 Diabetes Mellitus
  • Alpha-1 Antitrypsin
  • Edmonton, Alberta, Canada
    University of Alberta
May 23, 2022

MIP-1 Alpha and IL-6 in Saliva of Post Myocardial Infarction and

Completed
  • Myocardial Infarction
  • Periodontal Diseases
  • salivary test
  • Mangalore, India
    AB shetty Institute of dental sciences
Mar 29, 2022

Alpha1 Anti-Trypsin Deficiency Trial in United Kingdom (ZF874, Placebo)

Terminated
  • Alpha1 Anti-Trypsin Deficiency
  • Manchester, Greater Manchester, United Kingdom
  • +4 more
Sep 15, 2022

Pulmonary Emphysema in Alpha-1 PI Deficiency Trial in Worldwide (Alpha-1 MP, 0.9% Sodium Chloride for Injection, USP)

Recruiting
  • Pulmonary Emphysema in Alpha-1 PI Deficiency
  • Alpha-1 MP
  • 0.9% Sodium Chloride for Injection, USP
  • Phoenix, Arizona
  • +50 more
Dec 7, 2022

Bilateral Breast Carcinoma, Breast Inflammatory Carcinoma, Stage IB Breast Cancer AJCC v7 Trial in United States (drug, other,

Active, not recruiting
  • Bilateral Breast Carcinoma
  • +11 more
  • Scottsdale, Arizona
  • +11 more
Jan 12, 2023

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Metastatic

Not yet recruiting
  • FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
  • +4 more
  • Computed Tomography
  • +3 more
  • (no location specified)
Sep 13, 2022

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Cabozantinib S-malate
  • +7 more
  • (no location specified)
Jan 4, 2023

Evaluation of New Biomarkers in Stage 3 and 4 Endometriosis

Completed
  • Endometriosis
  • endometriosis surgery
  • other benign condition surgeries
  • Istanbul, Bagcilar, Turkey
    Bagcilar Teaching and Research Hospital
Mar 26, 2022

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)

Withdrawn
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jul 7, 2022

Asthma, COPD, Bronchiectasis Trial in Hamilton (Hyperpolarized 129Xe MRI)

Recruiting
  • Asthma
  • +7 more
  • Hyperpolarized 129Xe MRI
  • Hamilton, Ontario, Canada
    Firestone Institute for Respiratory Health, St. Joseph's Healthc
Sep 7, 2022

Biliary Atresia Trial in Worldwide (OCA 0.1mg, OCA 1.5mg, OCA 5mg)

Active, not recruiting
  • Biliary Atresia
  • OCA 0.1mg
  • +2 more
  • Brussel, Belgium
  • +16 more
May 6, 2022

T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • T Acute Lymphoblastic Leukemia
  • T Lymphoblastic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 11, 2023

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Subclinical hypothyroïdism, Hypothalamic-Pituitary-Gonadal Axis

Not yet recruiting
  • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
  • +2 more
  • Measurement and comparison of leucocytosis and concentrations of CRP, procalcitonin, fibrinogen, ferritin, IL-1, IL-6, IL-10, TNF-alpha in both study arms
  • +2 more
  • Kraków, Poland
    Jagiellonian University Medical College, Department of Gynecolog
Apr 29, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Tumor Lysis Syndrome Trial in Houston (Pegloticase, Rasburicase)

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

CharacterisatiON of carDiac funCTion in Intensive Care Unit

Not yet recruiting
  • Heart Failure
  • +3 more
  • CMR
  • +7 more
  • Glasgow, United Kingdom
  • +1 more
Nov 21, 2022

DLBCL, High Grade B-Cell Lymphoma w/MYC & BCL2 or BCL6 Rearrangements, High Grade B-Cell Lymphoma w/MYC, BCL2 & BCL6

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 12, 2022

Plasma Cell Myeloma, Renal Failure Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Renal Failure
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jun 13, 2022

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023

    BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

    Active, not recruiting
    • BRCA1 Gene Mutation
    • +9 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Sep 16, 2022

    Volume Deficit in the Mid-face Trial in Canada (Revanesse Shape + with Lidocaine, Juvederm Voluma with Lidocaine.)

    Recruiting
    • Volume Deficit in the Mid-face
    • Revanesse Shape + with Lidocaine
    • Juvederm Voluma with Lidocaine.
    • Calgary, Alberta, Canada
    • +6 more
    Jun 9, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +14 more
    • Biopsy
    • +25 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jul 12, 2022

    Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Solid Tumor Trial in New Brunswick

    Active, not recruiting
    • Ann Arbor Stage III Non-Hodgkin Lymphoma
    • +2 more
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 28, 2023

    Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

    Recruiting
    • Metastatic Kidney Medullary Carcinoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023